Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Everest Re participates in a conference call with Benchmark » 04:55
11/23/21
11/23
04:55
11/23/21
04:55
RE

Everest Re

$273.85 /

+6.95 (+2.60%)

Analyst Harrigan holds a…

Analyst Harrigan holds a conference call with CFO Kocianic on November 23 hosted by Benchmark.

ShowHide Related Items >><<
RE Everest Re
$273.85 /

+6.95 (+2.60%)

RE Everest Re
$273.85 /

+6.95 (+2.60%)

11/18/21 Jefferies
Everest Re initiated with a Buy at Jefferies
11/18/21 Jefferies
Everest Re initiated with a Buy at Jefferies
11/01/21 BofA
Everest Re added to US 1 List, Progressive removed at BofA
08/16/21 Wolfe Research
Everest Re initiated with an Outperform at Wolfe Research
RE Everest Re
$273.85 /

+6.95 (+2.60%)

Initiation
Everest Re initiated with a Buy at Jefferies » 16:59
11/18/21
11/18
16:59
11/18/21
16:59
RE

Everest Re

$274.40 /

-4.04 (-1.45%)

Jefferies analyst Yaron…

Jefferies analyst Yaron Kinar initiated coverage of Everest Re with a Buy rating and $335 price target. Two of the key catalysts that investors had looked for - Reinsurance reserve strengthening and adding financial leverage - have now been executed, but the impact of the latter is not yet fully reflected in results, the analyst tells investors in a research note. Kinar adds that Everest Re is also still in the midst of the third catalyst - de-risking of the portfolio and shifting it to specialty insurance.

ShowHide Related Items >><<
RE Everest Re
$274.40 /

-4.04 (-1.45%)

RE Everest Re
$274.40 /

-4.04 (-1.45%)

11/18/21 Jefferies
Everest Re initiated with a Buy at Jefferies
11/01/21 BofA
Everest Re added to US 1 List, Progressive removed at BofA
08/16/21 Wolfe Research
Everest Re initiated with an Outperform at Wolfe Research
06/18/21
Fly Intel: Top five analyst downgrades
RE Everest Re
$274.40 /

-4.04 (-1.45%)

Initiation
Everest Re initiated with a Buy at Jefferies » 16:38
11/18/21
11/18
16:38
11/18/21
16:38
RE

Everest Re

/

+

Jefferies analyst Yaron…

Jefferies analyst Yaron Kinar initiated coverage of Everest Re with a Buy rating and $335 price target.

ShowHide Related Items >><<
RE Everest Re
/

+

RE Everest Re
/

+

11/01/21 BofA
Everest Re added to US 1 List, Progressive removed at BofA
08/16/21 Wolfe Research
Everest Re initiated with an Outperform at Wolfe Research
06/18/21
Fly Intel: Top five analyst downgrades
06/18/21 Citi
Everest Re downgraded to Neutral on valuation at Citi
RE Everest Re
/

+

Conference/Events
Everest Re participates in a conference call with Benchmark » 16:26
11/15/21
11/15
16:26
11/15/21
16:26
RE

Everest Re

$275.50 /

+0.8 (+0.29%)

Analyst Harrigan holds a…

Analyst Harrigan holds a conference call with CFO Kocianic on November 23 hosted by Benchmark.

ShowHide Related Items >><<
RE Everest Re
$275.50 /

+0.8 (+0.29%)

RE Everest Re
$275.50 /

+0.8 (+0.29%)

11/01/21 BofA
Everest Re added to US 1 List, Progressive removed at BofA
08/16/21 Wolfe Research
Everest Re initiated with an Outperform at Wolfe Research
06/18/21
Fly Intel: Top five analyst downgrades
06/18/21 Citi
Everest Re downgraded to Neutral on valuation at Citi
RE Everest Re
$275.50 /

+0.8 (+0.29%)

Over a month ago
Recommendations
Everest Re added to US 1 List, Progressive removed at BofA  08:49
11/01/21
11/01
08:49
11/01/21
08:49
RE

Everest Re

$261.79 /

-5.895 (-2.20%)

, PGR

Progressive

$94.83 /

-0.93 (-0.97%)

 
ShowHide Related Items >><<
RE Everest Re
$261.79 /

-5.895 (-2.20%)

PGR Progressive
$94.83 /

-0.93 (-0.97%)

RE Everest Re
$261.79 /

-5.895 (-2.20%)

08/16/21 Wolfe Research
Everest Re initiated with an Outperform at Wolfe Research
06/18/21
Fly Intel: Top five analyst downgrades
06/18/21 Citi
Everest Re downgraded to Neutral on valuation at Citi
06/18/21 Citi
Everest Re downgraded to Neutral from Buy at Citi
PGR Progressive
$94.83 /

-0.93 (-0.97%)

08/17/21 Evercore ISI
Progressive added to 'Tactical Underperform List' at Evercore ISI
08/16/21 Wolfe Research
Progressive initiated with an Underperform at Wolfe Research
07/16/21 Barclays
Progressive price target lowered to $84 from $86 at Barclays
07/09/21 BofA
Progressive added to US 1 List; Arch Capital removed at BofA
RE Everest Re
$261.79 /

-5.895 (-2.20%)

PGR Progressive
$94.83 /

-0.93 (-0.97%)

PGR Progressive
$94.83 /

-0.93 (-0.97%)

PGR Progressive
$94.83 /

-0.93 (-0.97%)

Earnings
Everest Re reports Q3 operating EPS ($1.34), consensus (76c) » 16:35
10/27/21
10/27
16:35
10/27/21
16:35
RE

Everest Re

$280.68 /

-5.95 (-2.08%)

Reports Q3 revenue…

Reports Q3 revenue $2.93B, two estimates $2.28B. Everest Re Group President & CEO Juan C. Andrade commented on the Company's results: "During the third quarter of 2021, Everest made significant progress toward the strategic plan objectives detailed in the June investor day presentation. We achieved outstanding top line premium growth across both of our insurance and reinsurance businesses, continued to improve the attritional profitability for our Insurance Division, remained focused on risk appetite discipline and the diversification of our business, demonstrated strong expense management, delivered excellent investment income results, opportunistically reduced our cost of capital, and returned capital to our shareholders. Despite the high frequency and severity of the natural catastrophe activity in the quarter, we also benefited from the de-risking of the CAT portfolio and we remain on track to achieve our total shareholder return objective. We continue to consistently demonstrate our ability to relentlessly execute against our plans regardless of the external environment."

ShowHide Related Items >><<
RE Everest Re
$280.68 /

-5.95 (-2.08%)

RE Everest Re
$280.68 /

-5.95 (-2.08%)

08/16/21 Wolfe Research
Everest Re initiated with an Outperform at Wolfe Research
06/18/21
Fly Intel: Top five analyst downgrades
06/18/21 Citi
Everest Re downgraded to Neutral on valuation at Citi
06/18/21 Citi
Everest Re downgraded to Neutral from Buy at Citi
RE Everest Re
$280.68 /

-5.95 (-2.08%)

Hot Stocks
Everest Re sees Q3 catastrophe losses $635M » 08:44
10/14/21
10/14
08:44
10/14/21
08:44
RE

Everest Re

$266.27 /

+0.5 (+0.19%)

Everest Re Group,…

Everest Re Group, announced preliminary third quarter 2021 catastrophe losses in advance of its full quarterly earnings to be released on October 27. Everest is estimating total pre-tax net catastrophe losses of $635M for the third quarter 2021.

ShowHide Related Items >><<
RE Everest Re
$266.27 /

+0.5 (+0.19%)

RE Everest Re
$266.27 /

+0.5 (+0.19%)

08/16/21 Wolfe Research
Everest Re initiated with an Outperform at Wolfe Research
06/18/21
Fly Intel: Top five analyst downgrades
06/18/21 Citi
Everest Re downgraded to Neutral on valuation at Citi
06/18/21 Citi
Everest Re downgraded to Neutral from Buy at Citi
RE Everest Re
$266.27 /

+0.5 (+0.19%)

Syndicate
Everest Re files automatic mixed securities shelf  17:20
09/16/21
09/16
17:20
09/16/21
17:20
RE

Everest Re

$252.15 /

-1.41 (-0.56%)

 
ShowHide Related Items >><<
RE Everest Re
$252.15 /

-1.41 (-0.56%)

RE Everest Re
$252.15 /

-1.41 (-0.56%)

08/16/21 Wolfe Research
Everest Re initiated with an Outperform at Wolfe Research
06/18/21
Fly Intel: Top five analyst downgrades
06/18/21 Citi
Everest Re downgraded to Neutral on valuation at Citi
06/18/21 Citi
Everest Re downgraded to Neutral from Buy at Citi
RE Everest Re
$252.15 /

-1.41 (-0.56%)

Over a quarter ago
Initiation
Everest Re initiated with an Outperform at Wolfe Research » 16:37
08/16/21
08/16
16:37
08/16/21
16:37
RE

Everest Re

$271.72 /

-1.26 (-0.46%)

Wolfe Research analyst…

Wolfe Research analyst Michael Zaremski initiated coverage of Everest Re with an Outperform rating and $330 price target, citing what he views as a favorable risk/reward as well as "less reason for skepticism."

ShowHide Related Items >><<
RE Everest Re
$271.72 /

-1.26 (-0.46%)

RE Everest Re
$271.72 /

-1.26 (-0.46%)

06/18/21
Fly Intel: Top five analyst downgrades
06/18/21 Citi
Everest Re downgraded to Neutral on valuation at Citi
06/18/21 Citi
Everest Re downgraded to Neutral from Buy at Citi
03/31/21 Citi
Everest Re price target raised to $287 from $275 at Citi
RE Everest Re
$271.72 /

-1.26 (-0.46%)

Earnings
Everest Re reports Q2 operating EPS $14.63, consensus $7.78 » 16:44
07/28/21
07/28
16:44
07/28/21
16:44
RE

Everest Re

$243.55 /

-1.51 (-0.62%)

Reports Q2 revenue…

Reports Q2 revenue $3.08B, two estimates $2.38B. Everest Re Group President & CEO Juan C. Andrade commented on the Company's results: "Everest had an excellent quarter across the board with very strong growth and outstanding underwriting and investment performance. These results serve as the foundation for our exceptional net income result of $1.02 billion through the first half of 2021 and are another important step toward achieving our strategic plan objectives. Everest achieved an annualized Total Shareholder Return ("TSR") of 22.5% through the first half of 2021, exceeding our strategic plan target of 13.0%. Everest capitalized on market opportunities to expand our franchises in both reinsurance and insurance, driven by the relentless execution of our strategies and the valuable risk solutions provided to our customers and broker partners. Our focus on disciplined underwriting drove strong profitability in both reinsurance and insurance across our global operations. Finally, the standout performance this quarter demonstrates the quality of Everest's diversified earnings, and it is an important step toward achieving our strategic objectives and the commitments made to our shareholders."

ShowHide Related Items >><<
RE Everest Re
$243.55 /

-1.51 (-0.62%)

RE Everest Re
$243.55 /

-1.51 (-0.62%)

06/18/21
Fly Intel: Top five analyst downgrades
06/18/21 Citi
Everest Re downgraded to Neutral on valuation at Citi
06/18/21 Citi
Everest Re downgraded to Neutral from Buy at Citi
03/31/21 Citi
Everest Re price target raised to $287 from $275 at Citi
RE Everest Re
$243.55 /

-1.51 (-0.62%)

RE Everest Re
$243.55 /

-1.51 (-0.62%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.